Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Goto, S."'
Autor:
Sakurai Y; Division of Hematology/Oncology, Kanagawa Children's Medical Center., Iwasaki F; Division of Hematology/Oncology, Kanagawa Children's Medical Center., Hirose A; Division of Hematology/Oncology, Kanagawa Children's Medical Center., Matsumoto N; Division of Hematology/Oncology, Kanagawa Children's Medical Center., Miyagawa N; Division of Hematology/Oncology, Kanagawa Children's Medical Center., Keino D; Division of Hematology/Oncology, Kanagawa Children's Medical Center., Yokosuka T; Division of Hematology/Oncology, Kanagawa Children's Medical Center., Hamanoue S; Division of Hematology/Oncology, Kanagawa Children's Medical Center., Yanagimachi M; Division of Hematology/Oncology, Kanagawa Children's Medical Center., Shiomi M; Division of Hematology/Oncology, Kanagawa Children's Medical Center., Goto S; Division of Hematology/Oncology, Kanagawa Children's Medical Center., Tanaka M; Divisions of Pathology., Tanaka Y; Divisions of Pathology., Nozawa K; Radiology, Kanagawa Children's Medical Center, Yokohama, Japan., Goto H; Division of Hematology/Oncology, Kanagawa Children's Medical Center.
Publikováno v:
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2024 Jul 01; Vol. 46 (5), pp. 233-240. Date of Electronic Publication: 2024 Apr 29.
Autor:
Obama K; Division of Survivorship Research, National Cancer Center Institute for Cancer Control, Chuo-ku, Tokyo, Japan., Fujimori M; Division of Survivorship Research, National Cancer Center Institute for Cancer Control, Chuo-ku, Tokyo, Japan. Electronic address: mfujimor@ncc.go.jp., Boku N; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Matsuoka A; Division of Survivorship Research, National Cancer Center Institute for Cancer Control, Chuo-ku, Tokyo, Japan., Mori K; Department of Biostatistics, Clinical Research Center, Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan., Okizaki A; Innovation Center for Supportive, Palliative, and Psychosocial Care, National Cancer Center, Chuo-ku, Tokyo, Japan., Miyaji T; Division of Survivorship Research, National Cancer Center Institute for Cancer Control, Chuo-ku, Tokyo, Japan; Innovation Center for Supportive, Palliative, and Psychosocial Care, National Cancer Center, Chuo-ku, Tokyo, Japan., Okamura M; Division of Survivorship Research, National Cancer Center Institute for Cancer Control, Chuo-ku, Tokyo, Japan., Majima Y; NPO Pancreatic Cancer Action Network Japan, Sodegaura, Chiba, Japan., Goto S; Division of Survivorship Research, National Cancer Center Institute for Cancer Control, Chuo-ku, Tokyo, Japan., Shimazu T; Division of Survivorship Research, National Cancer Center Institute for Cancer Control, Chuo-ku, Tokyo, Japan., Uchitomi Y; Division of Survivorship Research, National Cancer Center Institute for Cancer Control, Chuo-ku, Tokyo, Japan; Innovation Center for Supportive, Palliative, and Psychosocial Care, National Cancer Center, Chuo-ku, Tokyo, Japan.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2024 Jun; Vol. 15 (5), pp. 101778. Date of Electronic Publication: 2024 May 04.
Autor:
Goto S; Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan., Goto S; Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan.
Publikováno v:
Circulation [Circulation] 2023 Nov 21; Vol. 148 (21), pp. 1677-1679. Date of Electronic Publication: 2023 Nov 20.
Autor:
Takimoto R; Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan; LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan. Electronic address: takimoto@j-immunother.com., Kamigaki T; Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Ito H; Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Saito M; Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Takizawa K; Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Soejima K; Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Yasuda H; Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Ohgino K; Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Terai H; Seta Clinic Group, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Tomita K; Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Miura M; Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Mizukoshi E; Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Miyashita T; Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Nakamoto Y; Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Hayashi K; Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Miwa S; Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Kitahara M; Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Takeuchi A; Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Kimura H; Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Mochizuki T; Kanazawa Advanced Medical Center, Kanazawa City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Sugie H; LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Seino KI; LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Yamada T; LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Takeuchi S; LSI Sapporo Clinic, Sapporo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Makita K; Kitaosaka Medical Clinic, Suita City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Naitoh K; Fukuoka Medical Clinic, Fukuoka City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Yasumoto K; Fukuoka Medical Clinic, Fukuoka City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Yoshida Y; Fukuoka Medical Clinic, Fukuoka City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Inoue H; Fukuoka Medical Clinic, Fukuoka City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Kotake K; Masuko Memorial Hospital, Nagoya City, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Ohshima K; Heisei-Hidaka Clinic, Gunma, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Noda SE; Heisei-Hidaka Clinic, Gunma, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Okamoto M; Heisei-Hidaka Clinic, Gunma, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Yoshimoto Y; Heisei-Hidaka Clinic, Gunma, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan., Okada S; Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan., Ibe H; Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan., Oguma E; Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan., Goto S; Seta Clinic Group, Tokyo, Japan; Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan; Cancer Immune-cell Therapy Evaluation Group (CITEG), Tokyo, Japan.
Publikováno v:
Cytotherapy [Cytotherapy] 2023 Nov; Vol. 25 (11), pp. 1229-1235. Date of Electronic Publication: 2023 Jul 22.
Autor:
Wang TF; Department of Medicine, University of Ottawa, The Ottawa Hospital, Ottawa Hospital Research Institute, Ottawa, Canada., Khorana AA; Department of Hematology and Medical Oncology Taussig Cancer Institute Cleveland Clinic Foundation, Cleveland, OH, USA., Agnelli G; Internal Vascular and Emergency Medicine - Stroke Unit, University of Perugia, Perugia, Italy., Bloomfield D; Anthos Therapeutics, Cambridge, MA, USA., Bonaca MP; Department of Medicine, Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA.; CPC Clinical Research, Aurora, CO, USA., Büller HR; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Connors JM; Hematology Division, Brigham and Women's Hospital, Boston, MA, USA., Goto S; Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan., Jing ZC; Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Kakkar AK; Thrombosis Research Institute, London, UK., Khder Y; Anthos Therapeutics, Cambridge, MA, USA., Raskob GE; Hudson College of Public Health University of Oklahoma Health Sciences Center Oklahoma City, OK, USA., Soff GA; General Hematology Service, University of Miami Health System/Sylvester Comprehensive Cancer Center, Miami, FL, USA., Verhamme P; Department of Cardiovascular Sciences, Vascular Medicine and Hemostasis, KU Leuven, Leuven, Belgium., Weitz JI; Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Canada., Carrier M; Department of Medicine, University of Ottawa, The Ottawa Hospital, Ottawa Hospital Research Institute, Ottawa, Canada.
Publikováno v:
The oncologist [Oncologist] 2023 Jul 05; Vol. 28 (7), pp. 555-564.
Autor:
Okamura M; Division of Supportive Care, Survivorship and Translational Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan., Fujimori M; Division of Supportive Care, Survivorship and Translational Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan., Goto S; Division of Supportive Care, Survivorship and Translational Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan., Obama K; Division of Supportive Care, Survivorship and Translational Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan., Kadowaki M; Division of Supportive Care, Survivorship and Translational Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan., Sato A; Division of Supportive Care, Survivorship and Translational Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan., Hirayama T; Department of Psycho-Oncology, National Cancer Center Hospital, Tokyo, Japan., Uchitomi Y; Division of Supportive Care, Survivorship and Translational Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Publikováno v:
Palliative & supportive care [Palliat Support Care] 2023 Feb; Vol. 21 (1), pp. 93-99.
Autor:
Gi T; Department of Pathology (T.G., A.Y., K.M., Y.A.), Faculty of Medicine, University of Miyazaki, Japan., Kuwahara A; Department of Laboratory Center (A.K.), Faculty of Medicine, University of Miyazaki, Japan., Yamashita A; Department of Pathology (T.G., A.Y., K.M., Y.A.), Faculty of Medicine, University of Miyazaki, Japan., Matsuda S; Department of Medicine and Community Health (S.M.), Faculty of Medicine, University of Miyazaki, Japan., Maekawa K; Department of Pathology (T.G., A.Y., K.M., Y.A.), Faculty of Medicine, University of Miyazaki, Japan., Moriguchi-Goto S; Department of Diagnostic Pathology' University of Miyazaki Hospital (S.M.-G., Y.S.), Faculty of Medicine, University of Miyazaki, Japan., Sato Y; Department of Diagnostic Pathology' University of Miyazaki Hospital (S.M.-G., Y.S.), Faculty of Medicine, University of Miyazaki, Japan., Asada Y; Department of Pathology (T.G., A.Y., K.M., Y.A.), Faculty of Medicine, University of Miyazaki, Japan.
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2023 Jan; Vol. 43 (1), pp. 146-159. Date of Electronic Publication: 2022 Nov 17.
Autor:
Nonami A; Center for Advanced Medical Innovation, Kyushu University, Fukuoka, Japan; Department of Medicine and Biosystemic Science, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: anonami@camiku.kyushu-u.ac.jp., Matsuo R; Department of Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Funakoshi K; Center for Clinical and Translational Research, Kyushu University Hospital, Fukuoka, Japan., Nakayama T; Department of Radiology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan., Goto S; Department of Next-Generation Cell and Immune Therapy, Juntendo University School of Medicine, Tokyo, Japan., Iino T; Center for Advanced Medical Innovation, Kyushu University, Fukuoka, Japan., Takaishi S; Center for Advanced Medical Innovation, Kyushu University, Fukuoka, Japan., Mizuno S; Center for Advanced Medical Innovation, Kyushu University, Fukuoka, Japan; Division of Medical Sciences and Technology, Department of Health Sciences, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan., Akashi K; Center for Advanced Medical Innovation, Kyushu University, Fukuoka, Japan; Department of Medicine and Biosystemic Science, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan., Eto M; Center for Advanced Medical Innovation, Kyushu University, Fukuoka, Japan; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Publikováno v:
Cytotherapy [Cytotherapy] 2023 Jan; Vol. 25 (1), pp. 76-81. Date of Electronic Publication: 2022 Oct 14.
Autor:
Potere N; Department of Medicine and Ageing Sciences, 'G. D'Annunzio' University, Chieti, Italy., Barco S; Department of Angiology, University Hospital Zurich, Zurich, Switzerland.; Center for Thrombosis and Hemostasis, Johannes Gutenberg University, Mainz, Germany., Mahé I; Université Paris Cité, Hôpital Louis Mourier, Paris, France.; Innovative Therapies in Haemostasis, INSERM UMR_S1140, Saint-Etienne, France., Cesarman-Maus G; Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico., Angchaisuksiri P; Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Leader A; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Okoye HC; Department of Haematology and Immunology, College of Medicine, University of Nigeria, Enugu, Nigeria., Olayemi E; Department of Haematology, University of Ghana Medical School, Accra, Ghana., Ay C; Department of Medicine I, Clinical Division of Haematology and Haemostaseology, Medical University Vienna, Vienna, Austria., Carrier M; Department of Medicine, University of Ottawa at The Ottawa Hospital, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Connors JM; Brigham and Women's Hospital, Hematology Division, Harvard Medical School, Boston, USA., Farmakis IT; Center for Thrombosis and Hemostasis, Johannes Gutenberg University, Mainz, Germany; Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Fumagalli RM; Department of Angiology, University Hospital Zurich, Zurich, Switzerland., Jing ZC; Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China., Lee LH; Department of Haematology, Singapore General Hospital, Singapore., McLintock C; National Women's Health, Auckland City Hospital, Auckland, New Zealand., Ní Ainle F; School of Medicine, University College Dublin, Dublin, Ireland., Giannakoulas G; Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Goto S; Department of Medicine, Tokai University School of Medicine, Isehara, Japan., Guillermo Esposito MC; Departamento Clínico de Medicina, Manuel Quintela Clinic Hospital, Montevideo, Uruguay., Jara-Palomares L; Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Virgen del Rocío, Sevilla, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain., Szlaszynska M; Department of Angiology, University Hospital Zurich, Zurich, Switzerland., Tan CW; Department of Haematology, Royal Adelaide Hospital, SA Pathology, Adelaide, South Australia, Australia, University of Adelaide, South Australia, Australia., Van Es N; Amsterdam UMC location University of Amsterdam, Vascular Medicine, Amsterdam, Netherlands; Amsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis, Amsterdam, the Netherlands., Wang TF; Department of Medicine, University of Ottawa at The Ottawa Hospital, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Hunt BJ; St Thomas' Hospital Thrombosis and Haemophilia Centre and Thrombosis and Vascular Biology Group, Guy's and St Thomas' NHS Foundation Trust, London, UK., Di Nisio M; Department of Medicine and Ageing Sciences, 'G. D'Annunzio' University, Chieti, Italy.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Dec; Vol. 20 (12), pp. 2964-2971. Date of Electronic Publication: 2022 Oct 21.
Autor:
Abdelghany L; Department of Stem Cell Biology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.; Department of Stem Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt., Zhang X; Department of Stem Cell Biology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.; Department of Stem Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan., Kawabata T; Department of Stem Cell Biology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.; Department of Stem Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan., Goto S; Department of Stem Cell Biology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.; Department of Stem Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan., El-Mahdy N; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt., Jingu K; Department of Radiation Oncology, Graduate School of Medicine, Tohoku University, Sendai, Japan., Li TS; Department of Stem Cell Biology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan. litaoshe@nagasaki-u.ac.jp.; Department of Stem Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan. litaoshe@nagasaki-u.ac.jp.
Publikováno v:
Medical oncology (Northwood, London, England) [Med Oncol] 2021 Nov 10; Vol. 39 (1), pp. 7. Date of Electronic Publication: 2021 Nov 10.